Suvretta Capital Management’s Sanofi SNY Stock Holding History

Suvretta Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,701	Closed	-$4.64M	–	106
2025 Q1	$4.64M	Sell	83,701 -47,800	-36%	-$2.59M	0.17%	64
2024 Q4	$6.34M	Sell	131,501 -43,400	-25%	-$2.21M	0.22%	61
2024 Q3	$10.1M	Sell	174,901 -35,800	-17%	-$1.93M	0.32%	53
2024 Q2	$10.2M	Hold	210,701	–	–	0.38%	49
2024 Q1	$10.2M	Buy	210,701 +39,700	+23%	+$1.94M	0.38%	50
2023 Q4	$8.5M	Buy	171,001 +54,960	+47%	+$2.69M	0.38%	47
2023 Q3	$6.22M	Hold	116,041	–	–	0.34%	49
2023 Q2	$6.25M	Buy	116,041 +93,431	+413%	+$5.03M	0.33%	56
2023 Q1	$1.23M	Hold	22,610	–	–	0.05%	77
2022 Q4	$1.1M	Buy	+22,610	New	+$992K	0.05%	69

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Suvretta Capital Management's SNY Position: Q2 2025 in Review

Suvretta Capital Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 83,701 shares — an estimated $4.64M sold.

Suvretta Capital Management first reported a position in SNY in Q4 2022 and held it in 10 quarters. The position peaked at $10.2M in Q1 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

Suvretta Capital Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
Suvretta Capital Management sold 83,701 Sanofi shares in Q2 2025, an estimated $4.64M.
Suvretta Capital Management first reported a position in Sanofi in Q4 2022 and held it in 10 quarters.
Suvretta Capital Management's Sanofi position peaked at $10.2M in Q1 2024.
731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.